Home · Reading room · Your questions
Your questionsGLP-1 options for endometriosis: what they do, what they don’t, and how providers compare
The honest version of this answer starts with a boundary — and then gets useful.
The short answer: there is no GLP-1 medication approved to treat endometriosis, and none should be offered to you as one. GLP-1s such as tirzepatide are prescribed for weight and metabolic health. If you have endometriosis, what matters when choosing a provider is whether they will coordinate with the endo care you already have — not whether they promise to improve it. Of the sixteen GLP-1 providers Havelle reviews, three reach our top tier for endometriosis-aware care: Alloy Women’s Health ($199/mo), Emerge Weight Loss ($224/mo) and Gaya Wellness ($349/mo), listed alphabetically, with no provider paying for placement.
Why this question deserves a careful answer
If you have endometriosis and you have started reading about GLP-1 medications, you have probably met two unhelpful extremes. One is the wellness-adjacent promise that a weekly injection will quiet everything, endo included. The other is a flat dismissal that leaves you with nothing to work with. Neither is the truth, and you deserve the version in between.
Here is the boundary, stated once and clearly: GLP-1 medications are not a treatment for endometriosis. There is no approved GLP-1 for endometriosis and no established evidence that these medications act on the disease. Endometriosis is managed by endometriosis care — your gynecologist or specialist, and the plan you have built with them.
What a GLP-1 program can be is one pillar of a wider picture. Weight and metabolic health matter for how you feel day to day, and they are worth real clinical attention. Any benefit you notice in your energy, your mobility or your general sense of being in your own body is downstream of that metabolic work — not evidence that the medication reached your endo.
The overlap nobody warns you about
The practical reason to choose carefully is not the disease. It is the symptom overlap. The most common side effects of GLP-1 medications are gastrointestinal — nausea, constipation, bloating — and a great many people with endometriosis already live with exactly those symptoms. If nobody wrote down your baseline before you started, then when things shift there is no way to tell a side effect from a flare, and you will be the one left sorting it out alone at 11pm.
So the question to bring to an intake call is not “will this help my endo?” It is “do you know what my normal looks like, and will you still be reachable when it changes?”
What endometriosis-aware care actually looks like
Havelle scores every provider against the same seven promises — the Whole-Woman Charter. In plain terms, a provider should: read your whole history rather than the number on the chart; listen instead of reaching for “just lose weight”; frame metabolic support honestly and never as endo treatment; titrate your dose to how you actually respond; put a human on the other end of a message when something goes wrong; have a maintenance and medically guided step-down plan so results hold; and publish a price you can read before you commit.
None of those seven is about the medication. All seven are about whether the care around it was built for someone with a second condition.
How the sixteen providers score
Three of the sixteen providers we review reach In Full Bloom, our top tier: Alloy Women’s Health at $199 a month, Emerge Weight Loss at $224, and Gaya Wellness at $349. They are listed alphabetically, which is how every list on this site is ordered — no provider can pay to be included or to place higher, there are no ads and no sponsored positions.
It is worth saying what that tier does and does not mean. It means those three scored strongest across the seven promises, not that any of them is perfect: no provider on our list scores full marks on all seven. It also has nothing to do with price. Nine of the sixteen providers cost less than the middle of that group, and the cheapest option on the board is $99 a month. If price is your deciding factor, that is a legitimate way to choose — our scoring simply answers a different question, which is who is likely to still be useful to you in month four.
One more honest note on the medication itself: the only FDA-approved tirzepatide products are Zepbound and Mounjaro. Compounded tirzepatide, which several providers on this list dispense, is not FDA-approved for safety, efficacy or quality, and the trial evidence behind the branded products does not carry over to a compounded version. A provider who is straight with you about that distinction is telling you something useful about how they will handle everything else.